pentobarbital will minimize the extent or outcome of fostemsavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will decrease the extent or impact of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.Contraindicated (one)pentobarbital will decrease the level